Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Pharmaceutical Contract Development and Manufacturing Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Pharmaceutical Contract Development and Manufacturing Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Pharmaceutical Contract Development and Manufacturing Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Pharmaceutical Manufacturing Services
    • 1.4.3 Biologics Manufacturing Services
    • 1.4.4 Drug Development Services
  • 1.5 Market by Application
    • 1.5.1 Global Pharmaceutical Contract Development and Manufacturing Market Share by Application: 2020 VS 2026
    • 1.5.2 Big Pharma
    • 1.5.3 Small Pharma
    • 1.5.4 Generic Pharma
    • 1.5.5 CRO
  • 1.6 Coronavirus Disease 2019 (Covid-19): Pharmaceutical Contract Development and Manufacturing Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Pharmaceutical Contract Development and Manufacturing Industry
      • 1.6.1.1 Pharmaceutical Contract Development and Manufacturing Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Pharmaceutical Contract Development and Manufacturing Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Pharmaceutical Contract Development and Manufacturing Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Pharmaceutical Contract Development and Manufacturing Market Perspective (2015-2026)
  • 2.2 Pharmaceutical Contract Development and Manufacturing Growth Trends by Regions
    • 2.2.1 Pharmaceutical Contract Development and Manufacturing Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Pharmaceutical Contract Development and Manufacturing Historic Market Share by Regions (2015-2020)
    • 2.2.3 Pharmaceutical Contract Development and Manufacturing Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Pharmaceutical Contract Development and Manufacturing Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Pharmaceutical Contract Development and Manufacturing Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Pharmaceutical Contract Development and Manufacturing Players by Market Size
    • 3.1.1 Global Top Pharmaceutical Contract Development and Manufacturing Players by Revenue (2015-2020)
    • 3.1.2 Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Pharmaceutical Contract Development and Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Pharmaceutical Contract Development and Manufacturing Market Concentration Ratio
    • 3.2.1 Global Pharmaceutical Contract Development and Manufacturing Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Pharmaceutical Contract Development and Manufacturing Revenue in 2019
  • 3.3 Pharmaceutical Contract Development and Manufacturing Key Players Head office and Area Served
  • 3.4 Key Players Pharmaceutical Contract Development and Manufacturing Product Solution and Service
  • 3.5 Date of Enter into Pharmaceutical Contract Development and Manufacturing Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Pharmaceutical Contract Development and Manufacturing Historic Market Size by Type (2015-2020)
  • 4.2 Global Pharmaceutical Contract Development and Manufacturing Forecasted Market Size by Type (2021-2026)

5 Pharmaceutical Contract Development and Manufacturing Breakdown Data by Application (2015-2026)

  • 5.1 Global Pharmaceutical Contract Development and Manufacturing Market Size by Application (2015-2020)
  • 5.2 Global Pharmaceutical Contract Development and Manufacturing Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Pharmaceutical Contract Development and Manufacturing Market Size (2015-2020)
  • 6.2 Pharmaceutical Contract Development and Manufacturing Key Players in North America (2019-2020)
  • 6.3 North America Pharmaceutical Contract Development and Manufacturing Market Size by Type (2015-2020)
  • 6.4 North America Pharmaceutical Contract Development and Manufacturing Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Pharmaceutical Contract Development and Manufacturing Market Size (2015-2020)
  • 7.2 Pharmaceutical Contract Development and Manufacturing Key Players in Europe (2019-2020)
  • 7.3 Europe Pharmaceutical Contract Development and Manufacturing Market Size by Type (2015-2020)
  • 7.4 Europe Pharmaceutical Contract Development and Manufacturing Market Size by Application (2015-2020)

8 China

  • 8.1 China Pharmaceutical Contract Development and Manufacturing Market Size (2015-2020)
  • 8.2 Pharmaceutical Contract Development and Manufacturing Key Players in China (2019-2020)
  • 8.3 China Pharmaceutical Contract Development and Manufacturing Market Size by Type (2015-2020)
  • 8.4 China Pharmaceutical Contract Development and Manufacturing Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Pharmaceutical Contract Development and Manufacturing Market Size (2015-2020)
  • 9.2 Pharmaceutical Contract Development and Manufacturing Key Players in Japan (2019-2020)
  • 9.3 Japan Pharmaceutical Contract Development and Manufacturing Market Size by Type (2015-2020)
  • 9.4 Japan Pharmaceutical Contract Development and Manufacturing Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Pharmaceutical Contract Development and Manufacturing Market Size (2015-2020)
  • 10.2 Pharmaceutical Contract Development and Manufacturing Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Pharmaceutical Contract Development and Manufacturing Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Pharmaceutical Contract Development and Manufacturing Market Size by Application (2015-2020)

11 India

  • 11.1 India Pharmaceutical Contract Development and Manufacturing Market Size (2015-2020)
  • 11.2 Pharmaceutical Contract Development and Manufacturing Key Players in India (2019-2020)
  • 11.3 India Pharmaceutical Contract Development and Manufacturing Market Size by Type (2015-2020)
  • 11.4 India Pharmaceutical Contract Development and Manufacturing Market Size by Application (2015-2020)

12 Central and South America

  • 12.1 Central and South America Pharmaceutical Contract Development and Manufacturing Market Size (2015-2020)
  • 12.2 Pharmaceutical Contract Development and Manufacturing Key Players in Central and South America (2019-2020)
  • 12.3 Central and South America Pharmaceutical Contract Development and Manufacturing Market Size by Type (2015-2020)
  • 12.4 Central and South America Pharmaceutical Contract Development and Manufacturing Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Thermo Fisher Scientific Inc.
    • 13.1.1 Thermo Fisher Scientific Inc. Company Details
    • 13.1.2 Thermo Fisher Scientific Inc. Business Overview and Its Total Revenue
    • 13.1.3 Thermo Fisher Scientific Inc. Pharmaceutical Contract Development and Manufacturing Introduction
    • 13.1.4 Thermo Fisher Scientific Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020))
    • 13.1.5 Thermo Fisher Scientific Inc. Recent Development
  • 13.2 Catalent, Inc.
    • 13.2.1 Catalent, Inc. Company Details
    • 13.2.2 Catalent, Inc. Business Overview and Its Total Revenue
    • 13.2.3 Catalent, Inc. Pharmaceutical Contract Development and Manufacturing Introduction
    • 13.2.4 Catalent, Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)
    • 13.2.5 Catalent, Inc. Recent Development
  • 13.3 Lonza Group Ltd
    • 13.3.1 Lonza Group Ltd Company Details
    • 13.3.2 Lonza Group Ltd Business Overview and Its Total Revenue
    • 13.3.3 Lonza Group Ltd Pharmaceutical Contract Development and Manufacturing Introduction
    • 13.3.4 Lonza Group Ltd Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)
    • 13.3.5 Lonza Group Ltd Recent Development
  • 13.4 Recipharm AB
    • 13.4.1 Recipharm AB Company Details
    • 13.4.2 Recipharm AB Business Overview and Its Total Revenue
    • 13.4.3 Recipharm AB Pharmaceutical Contract Development and Manufacturing Introduction
    • 13.4.4 Recipharm AB Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)
    • 13.4.5 Recipharm AB Recent Development
  • 13.5 Vetter Pharma International GMBH
    • 13.5.1 Vetter Pharma International GMBH Company Details
    • 13.5.2 Vetter Pharma International GMBH Business Overview and Its Total Revenue
    • 13.5.3 Vetter Pharma International GMBH Pharmaceutical Contract Development and Manufacturing Introduction
    • 13.5.4 Vetter Pharma International GMBH Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)
    • 13.5.5 Vetter Pharma International GMBH Recent Development
  • 13.6 FAMAR Health Care Services
    • 13.6.1 FAMAR Health Care Services Company Details
    • 13.6.2 FAMAR Health Care Services Business Overview and Its Total Revenue
    • 13.6.3 FAMAR Health Care Services Pharmaceutical Contract Development and Manufacturing Introduction
    • 13.6.4 FAMAR Health Care Services Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)
    • 13.6.5 FAMAR Health Care Services Recent Development
  • 13.7 AbbVie Inc.
    • 13.7.1 AbbVie Inc. Company Details
    • 13.7.2 AbbVie Inc. Business Overview and Its Total Revenue
    • 13.7.3 AbbVie Inc. Pharmaceutical Contract Development and Manufacturing Introduction
    • 13.7.4 AbbVie Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)
    • 13.7.5 AbbVie Inc. Recent Development
  • 13.8 Aenova Group
    • 13.8.1 Aenova Group Company Details
    • 13.8.2 Aenova Group Business Overview and Its Total Revenue
    • 13.8.3 Aenova Group Pharmaceutical Contract Development and Manufacturing Introduction
    • 13.8.4 Aenova Group Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)
    • 13.8.5 Aenova Group Recent Development
  • 13.9 Consort Medical plc
    • 13.9.1 Consort Medical plc Company Details
    • 13.9.2 Consort Medical plc Business Overview and Its Total Revenue
    • 13.9.3 Consort Medical plc Pharmaceutical Contract Development and Manufacturing Introduction
    • 13.9.4 Consort Medical plc Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)
    • 13.9.5 Consort Medical plc Recent Development
  • 13.10 Almac Group
    • 13.10.1 Almac Group Company Details
    • 13.10.2 Almac Group Business Overview and Its Total Revenue
    • 13.10.3 Almac Group Pharmaceutical Contract Development and Manufacturing Introduction
    • 13.10.4 Almac Group Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)
    • 13.10.5 Almac Group Recent Development
  • 13.11 Siegfried Holding AG
    • 10.11.1 Siegfried Holding AG Company Details
    • 10.11.2 Siegfried Holding AG Business Overview and Its Total Revenue
    • 10.11.3 Siegfried Holding AG Pharmaceutical Contract Development and Manufacturing Introduction
    • 10.11.4 Siegfried Holding AG Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)
    • 10.11.5 Siegfried Holding AG Recent Development
  • 13.12 Boehringer Ingelheim International GmbH
    • 10.12.1 Boehringer Ingelheim International GmbH Company Details
    • 10.12.2 Boehringer Ingelheim International GmbH Business Overview and Its Total Revenue
    • 10.12.3 Boehringer Ingelheim International GmbH Pharmaceutical Contract Development and Manufacturing Introduction
    • 10.12.4 Boehringer Ingelheim International GmbH Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)
    • 10.12.5 Boehringer Ingelheim International GmbH Recent Development
  • 13.13 Evonik Industries AG
    • 10.13.1 Evonik Industries AG Company Details
    • 10.13.2 Evonik Industries AG Business Overview and Its Total Revenue
    • 10.13.3 Evonik Industries AG Pharmaceutical Contract Development and Manufacturing Introduction
    • 10.13.4 Evonik Industries AG Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)
    • 10.13.5 Evonik Industries AG Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global Pharmaceutical Contract Development and Manufacturing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pharmaceutical Contract Development and Manufacturing development in North America, Europe, China, Japan, Southeast Asia, India and Central and South America.

    The key players covered in this study
    Thermo Fisher Scientific Inc.
    Catalent, Inc.
    Lonza Group Ltd
    Recipharm AB
    Vetter Pharma International GMBH
    FAMAR Health Care Services
    AbbVie Inc.
    Aenova Group
    Consort Medical plc
    Almac Group
    Siegfried Holding AG
    Boehringer Ingelheim International GmbH 
    Evonik Industries AG

    Market segment by Type, the product can be split into
    Pharmaceutical Manufacturing Services
    Biologics Manufacturing Services
    Drug Development Services
    Market segment by Application, split into
    Big Pharma
    Small Pharma
    Generic Pharma
    CRO

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central and South America

    The study objectives of this report are:
    To analyze global Pharmaceutical Contract Development and Manufacturing status, future forecast, growth opportunity, key market and key players.
    To present the Pharmaceutical Contract Development and Manufacturing development in North America, Europe, China, Japan, Southeast Asia, India and Central and South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of Pharmaceutical Contract Development and Manufacturing are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now